Medivie Therapeutic Ltd (MDVI) — Cash Flow-to-Debt Ratio
Medivie Therapeutic Ltd (MDVI) has a Cash Flow-to-Debt Ratio of -0.11x as of June 2021, meaning its operating cash flow of ILA-966.00K could theoretically repay 0% of its total liabilities (ILA9.13 Million) in one year. See MDVI current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Medivie Therapeutic Ltd Cash Flow-to-Debt Ratio (2010–2020)
Historical debt coverage capacity for Medivie Therapeutic Ltd across 11 annual periods. Also explore Medivie Therapeutic Ltd (MDVI) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Medivie Therapeutic Ltd (2010–2020)
Year-by-year debt coverage analysis for Medivie Therapeutic Ltd. For market capitalisation and broader financial context, see Medivie Therapeutic Ltd (MDVI) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2020 | -0.46x | ILA-3.88 Million | ILA8.46 Million | ▼ -3.6% |
| 2019 | -0.44x | ILA-3.37 Million | ILA7.61 Million | ▲ +62.0% |
| 2018 | -1.16x | ILA-5.03 Million | ILA4.32 Million | ▼ -35.8% |
| 2017 | -0.86x | ILA-2.96 Million | ILA3.45 Million | ▲ +56.7% |
| 2016 | -1.98x | ILA-3.57 Million | ILA1.80 Million | ▲ +38.2% |
| 2015 | -3.20x | ILA-3.54 Million | ILA1.10 Million | ▼ -84.1% |
| 2014 | -1.74x | ILA-3.00 Million | ILA1.72 Million | ▼ -28.1% |
| 2013 | -1.36x | ILA-2.79 Million | ILA2.05 Million | ▲ +84.2% |
| 2012 | -8.59x | ILA-12.52 Million | ILA1.46 Million | ▼ -491.5% |
| 2011 | -1.45x | ILA-13.74 Million | ILA9.46 Million | ▼ -43.7% |
| 2010 | -1.01x | ILA-9.65 Million | ILA9.55 Million | — |